Anticoags|Procoags Flashcards

(67 cards)

1
Q

Vessel damage = tissue factor (TF) release which binds with VIIa = conversion of X to Xa = small amount of thrombin

A

Initiation Phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Plts, V & XI activated by thrombin

A

Amplification Phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

-VIII, IX and calcium on plts = activation of X while thrombin activates plts, V, VIII =VIIIa-IXa complex
The VIIIa-IXa complex switches reaction to intrinsic tenase (Xase) pathway
So increased Xa = large amount of thrombin

A

Propagation Phase:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

this drug binds to antithrombin causing enhanced binding with thrombin which means?

A

heparin and if thrombin is bound..it is not available for clotting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

uses of heparin?

A
prevent/treat thrombus
PE
coronary syndromes
HD
CP bypass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

onset of subcu hep vs IV?

A

subcu 1-2 hours, IV immediate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is heparin affected by?

A

temperature, protein binding, pt variable anticoagulation response, renal & hepatic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

is heparin or LMWH [lovenox] more susceptible to temp, protein binding, renal/hepatic dz?

A

LMWH!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

3 lab values that can be used to monitor heparin and when to choose which one?

A
Low dose xa
high dose (bypass) ACT 350-400
aPTT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

therapeutic range of aPTT on hep?

A

1.5 - 2.5 x NL (N=30-35 sec)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is HIT

A

heparin induced thrombocytopenia

plt count <100,000 or 50% drop from baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA of HIT

A

heparin dependent antibodies trigger plt aggregation which causes thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Reversal of heparin?

A

protamine - 1 mg for each 100 units circulation heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

why do we overdose protamine?

A

protamine clearance is 20 min faster than heparin clearance (1/2 life 1 hr) so could run risk of heparin rebounding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

UFH & LMWH ↑ risk of neuraxial hematoma especially with

A

especially with NSAIDs, platelet inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

why is lmwh have more consistent pharmacokinetics and better bioavailability at lower doses

A

Less protein binding than heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

2 things to be cautious with when using LMWH

A

renal dz and its not antagonized by protamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Predictable onset (but delayed for 8-12 hrs) and duration, effective PO; requires lab monitoring, difficult to reverse, crosses placenta

A

Warfarin (Coumadin®)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

elimination half-life warfarin?

A

24-36 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Warfarin (Coumadin®) affected by

A

diet, drugs, ETOH, age, liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Monitoring warfarin is Best w PT but unreliable, what did we do to fix this

A

INR - moderate = 2-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Major surgery mgmt of warfarin?

A

Monitor INR peri-op; D/C 1-3 days pre-op; reinstitute 1-7 days post-op; UFH bridging for high-risk clotters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Reversal of warfarin?

A
Vitamin K (takes days)
PCCs for immediate reversal but availability issues FFP (transfusion risk and volume concerns)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

some examples of Newer Oral Anticoagulants (NOACs)

direct thrombin inhibitors

A

Dabigatran (Pradaxa®), Bivalirudin (Angiomax®, Angiox®), Argatroban (Arcova®)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
some examples of Newer Oral Anticoagulants (NOACs) | direct Xa inhibitors
Rivaroxaban (Xarelto®), Apixaban (Eliquis®), Fondaparinux (Arixtra®)
26
Advantages Newer Oral Anticoagulants (NOACs)
Rapid onset, therapeutic range within hours, no need for routine lab monitoring
27
disadvantages Newer Oral Anticoagulants (NOACs)
Needs adjusted dose with renal disease, no antagonists, unable to monitor w simple lab assays, ↑ inter-patient variability
28
common cause of death after first 24 hours post-trauma
PE
29
meds to use for VTE Prophylaxis
Heparin LMWH (Enoxaparin, Dalteparin) Xa inhibitors (Fondaparinux, Rivaroxaban) Thrombin inhibitors (Dabigatran, Argatroban)
30
Low risk Peri-op management with NOACs
D/C 24 hrs pre-op, resume 24 hrs post-op
31
Peri-op management with NOACs Mod-high risk
D/C 5 days pre-op, resume when risk of bleeding drops
32
Peri-op management with NOACs Elective procedures
Bridging probably not required; consider patient-specific risk/benefits
33
Peri-op management with NOACs ER procedures
Delay as long as possible; do not prophylax w recombinant VIIa (Novo 7) or PCCs
34
when should you Consider recombinant VIIa or PCCs
Life-threatening hemorrhage
35
Monitoring NOACs
aPTT and TT
36
IRREVERSIBLY inhibits cyclooxygenase = thromboxane A2 (7-10 days)
aspirin
37
when can you resume aspirin therapy?
24 hrs postop without bleeding
38
Thienopyridines examples
Clopidogrel (Plavix®); Prasugrel (Effient®); Ticagrelor (Brilinta®)
39
Thienopyridines MOA?
Binds to P2Y12 receptor = inhibits platelet activation and aggregation
40
Dual antiplatelet therapy ex
Thienopyridine (Plavix) + ASA
41
Dipyridamole (Persantine®) MOA?
↑ cyclic AMP  ↓ plt function
42
Dextran MOA
Binds to platelets = inhibited function
43
Platelet glycoprotein IIb/IIIa antagonists MOA
abciximab (ReoPro®); tirofiban (Aggrastat®); eptifibatide (Integrilin®) Bind or inhibit fibrinogen receptor = ↓ plt aggregation
44
Peri-op recommendations | Thienopyridines
D/C 7 days pre-op, avoid neuraxials until drug effects cleared
45
: Risks/benefits must be individualized, especially with elective procedures
ALL antiplatelets
46
Thrombolytics examples?
Streptokinase, urokinase, tissue plasminogen activator (tPA) (Alteplase®)
47
Thrombolytics MOA
Activates plasminogen to plasmin = clot breakdown
48
Use: Emergent treatment of PE, CVA, acute MI without PCI availability
Thrombolytics
49
Risks thrombolytics?
Intracranial hemorrhage; angioedema (especially with ACE inhibitor)
50
Treatment of too much thrombolytics?
Cryoprecipitate and/or platelets
51
Block conversion of plasminogen to plasmin = inhibited clot lysis [does not induce clotting, just prevents breakdown]
Tranexamic acid (TXA) & aminocaproic acid (Amicar®):
52
TXA Studies show
↓ blood loss, ↓ blood products; no ↑ risk of unwanted thrombi
53
TXA must be administered at
<3 hours post-injury
54
TXA reduces risk of death due to bleeding, regardless of the cause.”
CRASH-3 and WOMAN studies
55
Most efficacious dose TXA for non trauma patients?
15 mg/kg
56
Contraindications TXA?
Hypersensitivity to antifibrinolytics Acquired color vision deficit Caution with renal impairment Caution with thrombus history
57
reactions include: Anaphylaxis, pulmonary vasoconstriction with RV failure, hypotension
Protamine
58
Adverse reactions increased with protamine in patients who
NPH insulin, vasectomy, prior protamine, drug allergies
59
Analog of vasopressin, stimulates endothelial von Willebrand factor
Desmopressin (DDAVP)
60
Desmopressin (DDAVP) uses?
Mild hemophilia A, von Willebrand’s dz, cardiac surgery(?)
61
Binding site for IIb/IIIa receptors on platelets
fibrinogen
62
normal fibrinogen level and with pregnancy?
200-400 mg/dL; during pregnancy: >400 mg/dL
63
Elevated PT and PTT d/t ↓ fibrinogen should be treated with
cryoprecipitate or fibrinogen concentrates (can be refractory to FFP)
64
For hemophilia; off-label use for life-threatening hemorrhage VIIa + tissue factor = thrombin and amplified hemostasis Off-label use in CV surgery
Recombinant Factor VIIa (NovoSeven®)
65
Kcentra®, Octaplex®, FEIBA VH®, Profilnine®, Bebulin VH®
Prothrombin Complex Concentrates (PCCs)
66
Primary treatment for hemorrhage with ↑ INR when urgent reversal needed
Prothrombin Complex Concentrates (PCCs)
67
Compared to FFP: PCCs =
faster reversal, less volume, no cross-matching